Wealthcreatures.com
AURIONPRO Steady Numbers Q2FY24 Continues to grow at 30-35% maintaining the margins ( As Management had Guided Earlier) Revenue at 211cr vs 154cr⬆️37% EBITDA at 46cr vs 35cr⬆️32% OPM at 21.82% for q2 PBT at 40.5cr vs 29cr Q1 at 38cr PAT at 34cr vs 25cr…
AURIONPRO
Fresh 52wk & ATH TODAY
1633
Should do Well in coming Days
Already 410 To 1633 done till now
Still Longway to Go
Fresh 52wk & ATH TODAY
1633
Should do Well in coming Days
Already 410 To 1633 done till now
Still Longway to Go
Wealthcreatures.com
1.Persistent Systems Cmp - 6085 Accmumate - 5800 6085 zone Already given earlier also SL 5600 Test Levels - 10000/11000 if can wait for 18 months Short tem T 6800 2. REPL Cmp - 215 Accmulate bwt - 201 - 215 zone SL 184 Test levels - 280+…
SPANDANA SPOORTHY
PAT at Rs.116 cr vs Rs.50 cr,
up 2.3 Times YoY
PAT at Rs.116 cr vs Rs.50 cr,
up 2.3 Times YoY
DCW Limited has commissioned a Chlorinated Polyvinyl Chloride (CPVC) expansion project, increasing its production capacity by 10,000 MT at its Sahupuram Plant in Tamil Nadu.
The company plans to gradually ramp up production and commercialize the additional volumes. The total CPVC production capacity now stands at 20,000 MT.
The company plans to gradually ramp up production and commercialize the additional volumes. The total CPVC production capacity now stands at 20,000 MT.
Jehttps://www.bloomberg.com/news/articles/2023-10-30/jefferies-wood-says-india-stocks-may-fall-25-on-surprise-loss-of-modi-s-party#xj4y7vzkg
Jefferies Warns ⚠️ If BJP losses in 2024 stock mkts can see 25% Fall
What if BJP wins 🏆?
Answer is simple- Same % Of Upmove
Let's C
A
Jefferies Warns ⚠️ If BJP losses in 2024 stock mkts can see 25% Fall
What if BJP wins 🏆?
Answer is simple- Same % Of Upmove
Let's C
A
Wealthcreatures.com
LINCOLN PHARMA Only for Patience Holder Investment pick CMP - 240 ADD ON DIPS NEAR SUPPORT support @ 229/220 Promotors cont. Buying from open mkt. Good product line up TEST LEVELS # 300/400/500/600++ TF - 6/12/18/24 MONTHS S/L - 190 on closing…
Lincoln Pharma
Strong Set of Results for Q2
Fresh ATH 579 💚
Co. expects to achieve a Topline of Rs.750 crs. in FY26 (Current Topline FY23 is Rs.510 crs. & H1FY24 is Rs.308 crs.)
Co. has successfully completed expansion of the Cephalosporin plant at Mehsana, Gujarat. Commercial production from this plant has started. The plant is expected to contribute sales of around Rs. 150 crore in next 3 years
Won't be suprise to see 1000 + in next 2 years
Strong Set of Results for Q2
Fresh ATH 579 💚
Co. expects to achieve a Topline of Rs.750 crs. in FY26 (Current Topline FY23 is Rs.510 crs. & H1FY24 is Rs.308 crs.)
Co. has successfully completed expansion of the Cephalosporin plant at Mehsana, Gujarat. Commercial production from this plant has started. The plant is expected to contribute sales of around Rs. 150 crore in next 3 years
Won't be suprise to see 1000 + in next 2 years
Just an Observation
As you know market is a collection of opinions and move downside and upside based on these opinions.
In short term only opinions works if sentiment are positive for market each and every stock will rise, No matter earning or sales growth.
Same way if opinions are negative, each and every stocks will fall, even if some have strong earnings growth.
Now our focus should not be on opinions but on EARNING GROWTH
If a company business improving each year and business sustainability getting rise then we have to invest into those companies and hold without being carried away with market opinions.
As you know market is a collection of opinions and move downside and upside based on these opinions.
In short term only opinions works if sentiment are positive for market each and every stock will rise, No matter earning or sales growth.
Same way if opinions are negative, each and every stocks will fall, even if some have strong earnings growth.
Now our focus should not be on opinions but on EARNING GROWTH
If a company business improving each year and business sustainability getting rise then we have to invest into those companies and hold without being carried away with market opinions.